Form Type: 4

SEC EDGAR Link
Accession Number:0001193805-21-000014
Date:2021-01-04
Issuer: ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT)
Original Submission Date:

Reporting Person:

CHIVUKULA PAD
C/O ARCTURUS THERAPEUTICS HOLDINGS INC.
10628 SCIENCE CENTER DRIVE, SUITE 250 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-01-04 S 10,000 d $46.40 682,548 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f2 reflects the weighted average price of 10,000 shares of common stock of arcturus therapeutics holdings inc. sold by the reporting person in multiple transactions on january 4, 2021 with sale prices ranging from $43.74 to $50.36 per share. the reporting person undertakes to provide upon request by the u.s. securities and exchange commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
WhaleWisdom Logo

Elevate your investments